Virtual Medicinal Product (VMP)
-
Cytarabine 100mg/5ml solution for injection vials
Name Details
|
Current Name
Cytarabine 100mg/5ml solution for injection vials
|
Start Date
21-01-2009
|
End Date
|
|
Previous Name
Cytarabine 100mg/5ml solution for infusion vials
|
Start Date
16-01-2009
|
End Date
20-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intrathecal, Intravenous, Subcutaneous, Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninfusion.intravenous, solutioninjection.intrathecal, solutioninjection.intravenous, solutioninjection.subcutaneous, solutioninjection.intramuscular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01BC01
| BNF |
|
Current BNF
08010300
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
08010300
|
Start Date
09-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 4699111000001109 |
14-07-2003 |
|
VMP Ingredients
VMP ingredients table
| Cytarabine |
Based on Ingredient Substance |
|
20 mg |
1 ml |
Name
Cytarabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Cytarabine
-
VMP
(Current) Cytarabine 100mg/5ml solution for in...
Virtual Medicinal Product Pack (VMPP) Information